Literature DB >> 3743091

Recruitment of elderly volunteers for a multicenter clinical trial: the SHEP pilot study.

T M Vogt, C C Ireland, D Black, G Camel, G Hughes.   

Abstract

Few large trials have involved the elderly, and little is known about the feasibility of recruiting such participants for study and the validity of inferences drawn from them. This article reviews the recruitment experience of the Systolic Hypertension in the Elderly Program (SHEP) pilot study. That program involved five clinical centers, and contacted approximately 75,000 persons in order to enroll a cohort of 551 individuals over 60 years old isolated systolic hypertension. The enrolled cohort was somewhat older and more highly educated than those screened. Except for deliberate oversampling of blacks and those over 70 years old, the enrolled population resembled the U.S. population, although individuals in the SHEP group were initially healthier, and more likely to have had some college education than those in the general population. There was substantial variation among sites in number of staff hours spent per participant recruited. The SHEP experience indicates that older persons are willing to volunteer for clinical trials research and that problems of inference are probably not any greater for that age group than for any other.

Entities:  

Mesh:

Year:  1986        PMID: 3743091     DOI: 10.1016/0197-2456(86)90028-0

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  13 in total

1.  Primary prevention studies and the healthy elderly: evaluating barriers to recruitment.

Authors:  M Boles; W S Getchell; G Feldman; R McBride; R G Hart
Journal:  J Community Health       Date:  2000-08

Review 2.  The ethics of randomised controlled trials from the perspectives of patients, the public, and healthcare professionals.

Authors:  S J Edwards; R J Lilford; J Hewison
Journal:  BMJ       Date:  1998-10-31

3.  Problems encountered in recruiting patients to an ophthalmic drug trial.

Authors:  A M Quick; P T Khaw; A R Elkington
Journal:  Br J Ophthalmol       Date:  1989-06       Impact factor: 4.638

4.  Therapeutic choices for the older hypertensive patient.

Authors:  W B Applegate
Journal:  J Natl Med Assoc       Date:  1989-04       Impact factor: 1.798

5.  Factors associated with participation in a community senior health promotion program: a pilot study.

Authors:  D M Buchner; D C Pearson
Journal:  Am J Public Health       Date:  1989-06       Impact factor: 9.308

6.  Use of diuretics in treatment of hypertension in the elderly.

Authors:  W M Smith; D W Feigal; C D Furberg; M Greenlick; L Kuller; H M Perry; H W Schnaper; J A Schoenberger
Journal:  Drugs       Date:  1986       Impact factor: 9.546

Review 7.  Treatment of chronic non-malignant pain in the elderly: safety considerations.

Authors:  Jonathan Bruce Barber; Stephen J Gibson
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

8.  Enhancing participation of older women in surgical trials.

Authors:  Patricia S Goode; Mary P Fitzgerald; Holly E Richter; William E Whitehead; Ingrid Nygaard; Patricia A Wren; Halina M Zyczynski; Geoffrey Cundiff; Shawn Menefee; Judith M Senka; Xin Gao; Anne M Weber
Journal:  J Am Coll Surg       Date:  2008-05-19       Impact factor: 6.113

9.  Pharmacotherapy for hypertension in adults 60 years or older.

Authors:  Vijaya M Musini; Aaron M Tejani; Ken Bassett; Lorri Puil; James M Wright
Journal:  Cochrane Database Syst Rev       Date:  2019-06-05

Review 10.  First-line drugs for hypertension.

Authors:  James M Wright; Vijaya M Musini; Rupam Gill
Journal:  Cochrane Database Syst Rev       Date:  2018-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.